CN100364589C - A Chinese medicine for treating psoriasis - Google Patents
A Chinese medicine for treating psoriasis Download PDFInfo
- Publication number
- CN100364589C CN100364589C CNB2006100100452A CN200610010045A CN100364589C CN 100364589 C CN100364589 C CN 100364589C CN B2006100100452 A CNB2006100100452 A CN B2006100100452A CN 200610010045 A CN200610010045 A CN 200610010045A CN 100364589 C CN100364589 C CN 100364589C
- Authority
- CN
- China
- Prior art keywords
- grams
- radix
- root
- chinese medicine
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention discloses a Chinese drug for curing psoriasis, which is mainly formed by decocting the raw materials of liquid drugs of the weight distribution ratio of 4 to 6% of rehmannia root, 4 to 6% of red peony root, 4 to 6% of arctium fruit, 4 to 6% of herba schizonepetae, 4 to 6% of dittany bark, 6 to 10% of glabrous greenbrier rhizome, 4 to 6% of spatholobus stem, 2 to 4% of black-tail snake, 4 to 6% of honeysuckle stem, 5 to 8% of honeysuckle flower, 4 to 6% of ledebouriella root, 4 to 6% of forsythia fruit, 4 to 6% of cortex moutan, 4 to 6% of radix isatidis, 2 to 4% of flavescent sophora root, 4 to 6% of pagodatree flower bud, 4 to 6% of red sage root, 2 to 4% of raw licorice, 2 to 4% of asiatic moonseed and 4 to 6% of alkanna tinctoria. The sum of the raw materials is 100%. the Chinese drug of the present invention has a good therapeutic effect on curing psoriasis, itch, urticaria and itching skin disease and has the advantages of no toxic or side effect, stable effect and low recurrence rate.
Description
Technical field
The present invention relates to the field of Chinese medicines, be specifically related to the psoriatic Chinese medicine of a kind of treatment.
Background technology
Psoriasis is equivalent to the traditional Chinese medical science " chronic eczema ", " psoriasis ", clinical homeliness type, pustule type, joint type and the erythroderma type of generally being divided into.Psoriasis vulgaris is often with scalp erythema and the infringement of fingernail eedle shape.If erythra is based on the title psoriasis pustulosa of aseptic pustule; Be attended by the title psoriasis arthropathica of joint damage; The title erythrodermic psoriasis of general whole body flushing of erythra desquamation.The traditional Chinese medical science thinks that psoriatic morbidity is main relevant with heat in blood, noxious dampness, wind-dryness, blood stasis and Chong and Ren channel disorder.Modern medicine is thought silver-colored sick morbidity with heredity, infection, dysbolismus, same dyssecretosis, and neural Nervous and Mental Factors is relevant with all fixed factors of immunologic function disorder.The psoriatic medicine of most of at present treatment is all to coagulate plain therapy, and the antitumor thing is the most commonly used, most of toxic side effect, relapse rate height.
Summary of the invention
The psoriatic Chinese medicine of treatment that the object of the present invention is to provide a kind of short treating period, instant effect, have no side effect, relapse rate is low.
Chinese medicine of the present invention is selected all wind of Zaocys master, and is diffusing and not dry, is equipped with Herba Schizonepetae, Radix Saposhnikoviae with Jia Qili.Fructus Arctii dispelling wind and heat pathogens and moisturizing.Flos Lonicerae, Fructus Forsythiae, Caulis Lonicerae, Cortex Dictamni, Rhizoma Menispermi, Rhizoma Smilacis Glabrae, Radix Isatidis heat-clearing and toxic substances removing, the diffusing wind heat effect of removing heat from blood.The Radix Rehmanniae, Cortex Moutan, Radix Arnebiae (Radix Lithospermi), Flos Sophorae Immaturus clearing away heat and cooling blood, YIN nourishing and the production of body fluid promoting effect.Radix Salviae Miltiorrhizae invigorate blood circulation path, stasis-dispelling and pain-killing, the Caulis Spatholobi clearing away heat and cooling blood, blood circulation promoting and blood stasis dispelling is to strengthen curative effect.The Radix Sophorae Flavescentis heat clearing and damp drying, wind dispelling insecticide.The Radix Paeoniae Rubra clearing away heat and cooling blood, dissipating blood stasis is antipruritic.Radix Glycyrrhizae can heat-clearing and toxic substances removing again can coordinating the actions of various ingredients in a prescription.
For reaching better therapeutic, Chinese medicine of the present invention also makes up with Rhizoma Dioscoreae Bulbiferae, Ramulus Euonymi, Herba Portulacae.Stimulate the menstrual flow parasite killing, Herba Portulacae heat-clearing and toxic substances removing, cooling blood for hemostasis of Rhizoma Dioscoreae Bulbiferae removing toxic substances and promoting subsidence of swelling, Ramulus Euonymi makes curative effect of the present invention more.
The psoriatic Chinese medicine of a kind of treatment of the present invention, mainly made by following materials of weight proportions medicine: Radix Rehmanniae 4-6%, Radix Paeoniae Rubra 4-6%, Fructus Arctii 4-6%, Herba Schizonepetae 4-6%, Cortex Dictamni 4-6%, Rhizoma Smilacis Glabrae 6-10%, Caulis Spatholobi 4-6%, Zaocys 2-4%, Caulis Lonicerae 4-6%, Flos Lonicerae 5-8%, Radix Saposhnikoviae 4-6%, Fructus Forsythiae 4-6%, Cortex Moutan 4-6%, Radix Isatidis 4-6%, Radix Sophorae Flavescentis 2-4%, Flos Sophorae Immaturus 4-6%, Radix Salviae Miltiorrhizae 4-6%, Radix Glycyrrhizae 2-4%, Rhizoma Menispermi 2-4%, Radix Arnebiae (Radix Lithospermi) 4-6%, the crude drug sum is 100%.
Chinese medicine of the present invention also can add Rhizoma Dioscoreae Bulbiferae 2-4%, Ramulus Euonymi 2-4% and Herba Portulacae 4-6% on above-mentioned raw materials medicine basis.
Preparation method of the present invention: described materials of weight proportions medicine is decocted with water three times, and each amount of water was not advisable to have powder, merged three times decocting liquid, filtered and promptly got Chinese medicine of the present invention.Three times on the one, once take 100ml, take after 1 hour after meal.
Crude drug of the present invention is compatible, and the medicine that dispels the wind has the effect that improves body epidemic prevention ability, helps homeostasis and stops some poisonous immunoreactive generations.Heat and toxic materials clearing away medicine has stronger inhibition epidermis cell to increase too fast antiinflammatory, suppresses the humoral immunization effect.Heat removing and blood cooling medicine has inhibitory action to the pathogenic tinea bacterium of various skin.Drug for invigorating blood circulation and eliminating stasis can improve whole body and partial blood circulation, directly and indirectly plays antiphlogistic effect, and the utilization of primary disease activating blood and removing stasis drug may be by microcirculation improvement and skin-nourishing obstacle, suppresses the fast degree propagation of epidermis cell and obtains effect.The present invention treats psoriasis, tinea, urticaria, the dermatoses of itching etc. all good curative effect.And have no side effect, effect stability, relapse rate is low.
The specific embodiment
With crude drug: the Radix Rehmanniae 15 grams, Radix Paeoniae Rubra 15 grams, Fructus Arctii 15 grams, Herba Schizonepetae 15 grams, Cortex Dictamni 15 grams, Rhizoma Smilacis Glabrae 25 grams, Caulis Spatholobi 15 grams, Zaocys 10 grams, Caulis Lonicerae 15 grams, Flos Lonicerae 20 grams, Radix Saposhnikoviae 15 grams, Fructus Forsythiae 15 grams, Cortex Moutan 15 grams, Radix Isatidis 15 grams, Radix Sophorae Flavescentis 10 grams, the Flos Sophorae Immaturus 15 grams, Radix Salviae Miltiorrhizae 15 grams, Radix Glycyrrhizae 10 grams, Rhizoma Menispermi 10 grams, Radix Arnebiae (Radix Lithospermi) 15 grams.Decoct with water three times, each amount of water was not advisable to have powder, merged three times decocting liquid, filtered and promptly made Chinese medicine of the present invention.
With crude drug: the Radix Rehmanniae 15 grams, Radix Paeoniae Rubra 15 grams, Fructus Arctii 15 grams, Herba Schizonepetae 15 grams, Cortex Dictamni 15 grams, Rhizoma Smilacis Glabrae 25 grams, Caulis Spatholobi 15 grams, Zaocys 10 grams, Caulis Lonicerae 15 grams, Flos Lonicerae 20 grams, Radix Saposhnikoviae 15 grams, Fructus Forsythiae 15 grams, Cortex Moutan 15 grams, Radix Isatidis 15 grams, Radix Sophorae Flavescentis 10 grams, the Flos Sophorae Immaturus 15 grams, Radix Salviae Miltiorrhizae 15 grams, Radix Glycyrrhizae 10 grams, Rhizoma Menispermi 10 grams, Radix Arnebiae (Radix Lithospermi) 15 grams, Rhizoma Dioscoreae Bulbiferae 10 grams, Ramulus Euonymi 10 grams and Herba Portulacae 15 grams.Decoct with water three times, each amount of water was not advisable to have powder, merged three times decocting liquid, filtered and promptly made Chinese medicine of the present invention.
Treatment by Chinese herbs psoriatic's of the present invention clinical trial
1. physical data
Accept psoriatic's 50 examples for medical treatment, female patient 22 examples, male patient's 28 examples, the age is at 14-60 between year.Joint type 2 examples wherein; Folium Styracis Suberifoliae type 2 examples; Pus alveolitoid 2 examples; Homeliness type 44 examples.
2. diagnostic criteria
1) homeliness type
Erythra is sent out well in extremity and is stretched side (particularly elbow, knee joint are stretched face), secondly is trunk (particularly sacrum portion) and scalp, hairline.The total characteristics of erythra are: substrate is red macule, maculopapule, pimple or speckle, and clear border, surface coverage have the exsiccant silvery white squama of multilamellar.Squama is scraped easily, strike off squama after, as seen expose the translucent shinny thin film of one deck pale red (claim thin film phenomenon); Continue gently to scrape, cribriform little petechia then occurs, as dewdrops (claiming the petechial hemorrhage phenomenon or reveal to drip phenomenon).
2) joint type
Psoriatic erythra is arranged, articulate pathological changes.Invade little joints (as refer to, toe joint), or invade elbow, knee joint, sacroiliac joint and articuli intervertebrales etc.Symptom and arthromyodynia (rheumatoid arthritis) are similar, visible joint swelling and pain, and the active receiving restriction is so that ankylosis or joint deformity.But how asymmetric arthropathy is.General Symptomies such as heating, tired discomfort can be arranged.
3) pustule type
Psoriatic erythra is often arranged.Pustule is confined to slap sole of the foot portion (claiming the Pasfulosis palmaris et plantaris type again) more, and severe patient can general whole body (claiming general property pustule type again).On the basis of erythema, have and troop, syringe needle is to the pustule of foxtail millet grain size.Pustule can betide on the psoriatic erythra, also can betide the skin at non-psoriasis erythra place.Pustular infringement and rapid general whole body can take place suddenly in the original no psoriatic erythra of small number of patients, just engender psoriatic erythra later on.Often with heating, tired discomfort, General Symptomies such as arthralgia.General the visible hyperpyrexia of person, shiver with cold etc.
4) erythroderma type
Often betide in the therapeutic process of psoriasis vulgaris, because of malpractice causes.As at the stronger medicine of the phase of carrying out external zest, or use in the Western medicine corticosteroid hormone therapeutic process the too fast or unexpected drug withdrawal of decrement.Minority can be developed voluntarily by psoriasis vulgaris and form, and also has the only a few patient promptly to show as the erythroderma type at the beginning.Show as whole skin and be diffusivity flushing, dark red or purplish red, swelling, infiltration, a large amount of squamas of surface attachment, and constantly come off.At this moment, psoriatic features such as silvery white squama and petechial hemorrhage often disappear.Often General Symptomies such as hyperpyrexia, fear of cold, headache, tired discomfort can be arranged with heating.In case after erythroderma is controlled, can occur typical psoriatic erythra again.
3. Therapeutic Method
Oral the present invention treats psoriatic Chinese medicine, and three times on the one, a 100ml takes after 1 hour after meal.
4. curative effect determinate standard
Cure: skin lesion disappears, and the skin full recovery is normal.Produce effects: skin lesion disappears 70%～80%, and skin is most of to recover normal, only stays a little drop shape skin lesion.Invalid: the no significant change in 1 month of taking medicine.
5. result
Skin lesion disappeared gradually after Chinese medicine of the present invention was on average taken medicine one month, continued to take medicine and can cure in three months, cured the back and continued medication 2 months, prevented recurrence to consolidate curative effect.Cure: 45 examples; Produce effects: 3 examples; Invalid: 2 examples.Cure rate reaches 90%, and total effective rate reaches 96%.
Claims (5)
1. treat psoriatic Chinese medicine for one kind, it is characterized in that: mainly made by following materials of weight proportions medicine: Radix Rehmanniae 4-6%, Radix Paeoniae Rubra 4-6%, Fructus Arctii 4-6%, Herba Schizonepetae 4-6%, Cortex Dictamni 4-6%, Rhizoma Smilacis Glabrae 6-10%, Caulis Spatholobi 4-6%, Zaocys 2-4%, Caulis Lonicerae 4-6%, Flos Lonicerae 5-8%, Radix Saposhnikoviae 4-6%, Fructus Forsythiae 4-6%, Cortex Moutan 4-6%, Radix Isatidis 4-6%, Radix Sophorae Flavescentis 2-4%, Flos Sophorae Immaturus 4-6%, Radix Salviae Miltiorrhizae 4-6%, Radix Glycyrrhizae 2-4%, Rhizoma Menispermi 2-4%, Radix Arnebiae (Radix Lithospermi) 4-6%, the crude drug sum is 100%.
2. the psoriatic Chinese medicine of the described a kind of treatment of root a tree name claim 1 is characterized in that: crude drug: the Radix Rehmanniae 15 grams, Radix Paeoniae Rubra 15 grams, Fructus Arctii 15 grams, Herba Schizonepetae 15 grams, Cortex Dictamni 15 grams, Rhizoma Smilacis Glabrae 25 grams, Caulis Spatholobi 15 grams, Zaocys 10 grams, Caulis Lonicerae 15 grams, Flos Lonicerae 20 grams, Radix Saposhnikoviae 15 grams, Fructus Forsythiae 15 grams, Cortex Moutan 15 grams, Radix Isatidis 15 grams, Radix Sophorae Flavescentis 10 grams, the Flos Sophorae Immaturus 15 grams, Radix Salviae Miltiorrhizae 15 grams, Radix Glycyrrhizae 10 grams, Rhizoma Menispermi 10 grams, Radix Arnebiae (Radix Lithospermi) 15 grams.
3. the psoriatic Chinese medicine of the described a kind of treatment of root a tree name claim 1 is characterized in that wherein crude drug also has: Rhizoma Dioscoreae Bulbiferae 2-4%, Ramulus Euonymi 2-4% and Herba Portulacae 4-6%.
4. the psoriatic Chinese medicine of the described a kind of treatment of root a tree name claim 3 is characterized in that: crude drug: the Radix Rehmanniae 15 grams, Radix Paeoniae Rubra 15 grams, Fructus Arctii 15 grams, Herba Schizonepetae 15 grams, Cortex Dictamni 15 grams, Rhizoma Smilacis Glabrae 25 grams, Caulis Spatholobi 15 grams, Zaocys 10 grams, Caulis Lonicerae 15 grams, Flos Lonicerae 20 grams, Radix Saposhnikoviae 15 grams, Fructus Forsythiae 15 grams, Cortex Moutan 15 grams, Radix Isatidis 15 grams, Radix Sophorae Flavescentis 10 grams, the Flos Sophorae Immaturus 15 grams, Radix Salviae Miltiorrhizae 15 grams, Radix Glycyrrhizae 10 grams, Rhizoma Menispermi 10 grams, Radix Arnebiae (Radix Lithospermi) 15 grams, Rhizoma Dioscoreae Bulbiferae 10 grams, Ramulus Euonymi 10 grams and Herba Portulacae 15 grams.
5. root a tree name claim 1,2, the psoriatic preparation method of Chinese medicine of 3 or 4 described a kind of treatments is characterized in that: described materials of weight proportions medicine is decocted with water three times, and each amount of water was not advisable to have powder, merged three times decocting liquid, and filtration promptly.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100100452A CN100364589C (en) | 2006-05-15 | 2006-05-15 | A Chinese medicine for treating psoriasis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2006100100452A CN100364589C (en) | 2006-05-15 | 2006-05-15 | A Chinese medicine for treating psoriasis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1879784A CN1879784A (en) | 2006-12-20 |
| CN100364589C true CN100364589C (en) | 2008-01-30 |
Family
ID=37518285
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2006100100452A Expired - Fee Related CN100364589C (en) | 2006-05-15 | 2006-05-15 | A Chinese medicine for treating psoriasis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100364589C (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106344768A (en) * | 2016-11-11 | 2017-01-25 | 成都悦伦商贸有限公司 | Traditional Chinese medicine compound for treating psoriasis |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101897868B (en) * | 2010-06-28 | 2012-01-11 | 赵子山 | Chinese medicinal composition for treating psoriasis and preparation method thereof |
| CN102885991B (en) * | 2012-09-06 | 2014-02-12 | 山东省立医院 | Oral medicine for effectively treating urticaria |
| CN103211899B (en) * | 2012-11-02 | 2014-07-16 | 魏晓文 | Method for treating psoriasis |
| CN103381247B (en) * | 2013-04-25 | 2015-04-22 | 苏州谷力生物科技有限公司 | Traditional Chinese medicinal composition for treating psoriasis |
| CN103251850A (en) * | 2013-05-24 | 2013-08-21 | 苏州谷力生物科技有限公司 | Traditional Chinese medicine mixture for treating psoriasis |
| CN103830632A (en) * | 2014-03-26 | 2014-06-04 | 刘洪� | Chinese traditional medicine preparation for radically treating psoriasis and multiple skin diseases and preparation method and application thereof |
| CN104721405A (en) * | 2015-03-05 | 2015-06-24 | 兰建国 | Orally taken traditional Chinese medicine for treating various stubborn dermatitis and psoriasis |
| CN104825944B (en) * | 2015-04-24 | 2018-03-06 | 平阴县中医医院 | A kind of medicine for treating blood-head psoriasis pustulosa |
| CN105853854A (en) * | 2016-04-28 | 2016-08-17 | 哈尔滨摆渡新材料有限公司 | Traditional Chinese medicinal ointment for treating psoriasis and preparation method of traditional Chinese medicinal ointment |
| CN110833583A (en) * | 2019-12-12 | 2020-02-25 | 亢跃进 | Traditional Chinese medicine for treating psoriasis and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1189343A (en) * | 1997-01-28 | 1998-08-05 | 黄北原 | Powder for curing psoriasis |
| CN1242201A (en) * | 1998-07-20 | 2000-01-26 | 徐景信 | Patent traditional Chinese medicine for treating psoriasis, and method for preparing same |
-
2006
- 2006-05-15 CN CNB2006100100452A patent/CN100364589C/en not_active Expired - Fee Related
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1189343A (en) * | 1997-01-28 | 1998-08-05 | 黄北原 | Powder for curing psoriasis |
| CN1242201A (en) * | 1998-07-20 | 2000-01-26 | 徐景信 | Patent traditional Chinese medicine for treating psoriasis, and method for preparing same |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106344768A (en) * | 2016-11-11 | 2017-01-25 | 成都悦伦商贸有限公司 | Traditional Chinese medicine compound for treating psoriasis |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1879784A (en) | 2006-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100364589C (en) | A Chinese medicine for treating psoriasis | |
| CN101167847B (en) | Traditional Chinese medicinal white spirit preparation for effectively treating skin disease | |
| CN101934025B (en) | Traditional Chinese medicine for clearing away heat and toxic material | |
| CN100434107C (en) | Acne clearing decoction | |
| CN103055130A (en) | Traditional Chinese medicine composition for treating chronic pharyngitis and preparation method thereof | |
| CN101327298B (en) | Chinese medicine for treating pruritus dermatopathy | |
| CN103356868A (en) | Chinese medicinal capsule for treatment of psoriasis | |
| CN101062198A (en) | Decoction for treating arthritis | |
| CN101653540B (en) | Traditional Chinese medicine composition for treating pustule type psoriasis | |
| CN103784804A (en) | Pharmaceutical composition for treating benign prostatic hyperplasia | |
| CN102406870B (en) | Medicament for treating rheumatic arthralgia | |
| CN102078432A (en) | Medicament for treating skin itch | |
| CN101085303A (en) | Oral administration traditional Chinese medicine composition for treating hyperplasia of mammary glands | |
| CN104623532A (en) | Traditional Chinese medicine composition for treating glioma and preparation method thereof | |
| CN104771516A (en) | Traditional Chinese medicine composition for treating allergic dermatitis | |
| CN104288597A (en) | Traditional Chinese medicine composition for treating herpes zoster | |
| CN109646662A (en) | It is a kind of to treat psoriasic traditional Chinese medicine for oral administration side | |
| CN103463560A (en) | Traditional Chinese medicine composition for treating rosacea | |
| CN1236806C (en) | Liver-tonifying stone-removing Chinese medicine | |
| CN103463412A (en) | Traditional Chinese medicinal composition for treating oral ulcer | |
| CN1202858C (en) | Medication for psoriasis and its preparation method | |
| CN104771580A (en) | Traditional Chinese medicine composition for treating prostatitis | |
| CN1382486A (en) | Fengshitongluo wan for treating rheumatism | |
| CN104971209A (en) | Externally used agent for treating tinea pedis and preparation method thereof | |
| CN104758567A (en) | Traditional Chinese medicine for treating angiitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080130 Termination date: 20100515 |